Selective serotonin reuptake inhibitor use during pregnancy increases the risk of postpartum hemorrhage and anemia: a hospital-based cohort study-Reference-Cited by-同舟云学术

Selective serotonin reuptake inhibitor use during pregnancy increases the risk of postpartum hemorrhage and anemia: a hospital-based cohort study

Published:2014-11-14 Issue:12 Volume:12 Page:1986-1992
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Lindqvist P. G.¹,Nasiell J.¹,Gustafsson L. L.²,Nordstrom L.³

Affiliation:

1. Division of Obstetrics and Gynecology; Department of Clinical Science, Intervention and Technology (Clintec); Karolinska Institutet at Karolinska University Hospital; Stockholm Sweden

2. Division of Clinical Pharmacology; Department of Laboratory Medicine; Karolinska Institutet at Karolinska University Hospital; Stockholm Sweden

3. Department of Children′s and Women′s Health; Karolinska Institutet at Karolinska University Hospital; Stockholm Sweden

Funder

The Department of Clinical Science, Intervention and Technology (Clintec) at Karolinska Institutet in Stockholm

Swedish Research Council

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.12757/fullpdf

Reference24 articles.

1. The epidemiology of postpartum hemorrhage in a large, nationwide sample of deliveries;Bateman;Anesth Analg,2010

2. Postpartum hemorrhage in resource-poor settings;Geller;Int J Gynaecol Obstet,2006

3. Prevalence and patterns of antidepressant drug use during pregnancy;Ververs;Eur J Clin Pharmacol,2006

4. Combined use of selective serotonin reuptake inhibitors and sedatives/hypnotics during pregnancy: risk of relatively severe congenital malformations or cardiac defects. A register study;Reis;BMJ Open,2013

5. The molecular neurobiology of depression;Krishnan;Nature,2008

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safe Deprescribing of Antidepressants;The Maudsley Deprescribing Guidelines – Antidepressants, Benzodiazepines, Gabapentinoids and Z‐drugs;2024-08-30

2. The Risk of Postpartum Hemorrhage with Selective Serotonin Reuptake Inhibitors and Serotonin Norepinephrine Reuptake Inhibitors: Preliminary Results from the Massachusetts General Hospital National Pregnancy Registry for Psychiatric Medications;Journal of Women's Health;2024-07-22

3. Dose-dependent increase in risk of bleeding and bleeding complications in relation to SSRI use at delivery;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-05

4. Risk of abnormal uterine bleeding associated with high-affinity compared with low-affinity serotonin and norepinephrine reuptake inhibitors;Journal of Affective Disorders;2024-04

5. Concomitant Use of Selective Serotonin Reuptake Inhibitors With Oral Anticoagulants and Risk of Major Bleeding;JAMA Network Open;2024-03-22